Four purine arabinosides that inhibit varicella-zoster virus (VZV)replication in vitro were tested as inhibitors of colony formation by progenitor cells from normal human bone marrow. In general, erythroid burst forming cells (BFU-E) were more sensitive to inhibition by . these compounds than were either erythroid colony forming cells (CFU-E) or granulocyte/macrophage colony forming cells (CFU-GM). A 50% reduction in colony formation (IC so ) was observed for BFU-E in the presence of 8 fLM 6-methoxypurine arabinoside. Adenine arabinoside and hypoxanthine arabinoside had IC sa values of 1 fLM and 4 fLM respectively, whereas 6-ethoxypurine arabinoside was not inhibitory (IC so > 50 fLM). Enzyme studies showed that both 6-methoxypurine arabinoside and adenine arabinoside were converted to hypoxanthine arabinoside by adenosine deaminase. 6-Ethoxypurine arabinoside was a much less efficient substrate. When the BFU-E assays were performed in the presence of an inhibitor of adenosine deaminase, 6-methoxypurine arabinoside became non-inhibitory. In contrast, adenine arabinoside became much more inhibitory (IC sa = 0.03 fLM). The potency of hypoxanthine arabinoside was unaffected. Thus, incubation of 6-methoxypurine arabinoside and adenine arabinoside under conditions appropriate for the BFU-E assay resulted in the in situ conversion of these compounds to hypoxanthine arabinoside. Biotransformation of compounds must be considered in the assessment of toxicity in vitro. . 'For correspondence. Tel. 919 24 84 276; Fax 919 248 8375.
Introduction
Mature blood elements of the peripheral blood are derived by the differentiation of primitive, lineage specific stem cells residing in the bone marrow (Clark and Kamen, 1987) . The development of clonal assay systems for the culture of these bone marrow progenitor cells has contributed to our understanding of the properties of stem cells and the interactions that regulate their proliferation and differentiation. Such assays have also become useful tools in assessing the potential for bone marrow toxicities arising from the use of chemotherapeutic agents (Parker et al., 1982; Sommadosi and Carlisle, 1987; Ganser et al., 1989; Inoue et aI., 1989) . Although other toxicities may be dose limiting to the use of a therapeutic agent in vivo, the in vitro evaluation of progenitor cell toxicity may be helpful in anticipating potential clinical difficulties.
The potent and selective activity of 6-methoxypurine arabinoside (ara-M) against varicella-zoster virus ryZV) has been previously described (Averett et al., 1991) . In the present report, we describe studies on the ability of the arabinosides of hypoxanthine, adenine, 6-methoxypurine, and 6-ethoxypurine to inhibit the growth of erythroid and granulocyte-macrophage progenitor cells in vitro.
Results
The ability of the arabinosides of hypoxanthine, adenine, 6-methoxypurine, and 6-ethoxypurine to affect growth of different progenitor cells varied as a function of both the aglycon and of the cell type. CFU-GM colonies were least susceptible to inhibition (Table 1) , whereas BFU-E were most susceptible. The rank order of potency of the arabinosides was retained for the various cell types. The most potent inhibitor was ara-A, followed by ara-H, ara-M, and 6-ethoxypurine arabinoside. Since ara-A is known to be converted to ara-H in the presence of adenosine deaminase (Brink and LePage, 1964) , the BFU-E assays were repeated in the presence of EHNA, a potent and selective inhibitor of this enzyme (Schaeffer and Schwender, 1974) . Under these conditions, ara-A was thirty-fold more potent (Fig. 1) . In marked contrast, ara-M was not an effective inhibitor of BFU-E in the presence of EHNA (Fig.  1 ). The potency of ara-H was not significantly affected.
The growth inhibition results described here and elsewhere (Averett et al., 1991) suggested that adenosine deaminase activity plays a role in decreasing the toxicity of adenosine arabinoside and in increasing the toxicity of % of Control ara-M, For this reason, it was desirable to quantitatively compare the substrate efficiency of the arabinosides of adenine, 6-methoxypurine, and 6-ethoxypurine. Adenosine deaminase was able to convert each of these compounds to ara-H, The reaction product was confirmed as ara-H by spectroscopy (Methods and Experimental procedures). Ara-A had a K m of 66ILM and a V max which was 15% of the V max of adenosine. In contrast, the 6-alkoxypurine arabinosides were less efficient substrates (Vmax/Kml (Table 2 ). Compared to ara-A, the K m of ara-M was higher (120 ILM) and the Vmax was lower by a factor of 200. The K m of 6-ethoxypurine arabinoside was much larger (1500ILM) and also the V max was decreased by an additional factor of 4. Both ara-M and 6-ethoxypurine arabinoside were competitive alternate substrate inhibitors of adenosine deamination, with Kj values of 140 ILM and 1500 ILM, respectively (Table 2) . more mature erythroid precursor CFU-E had an intermediate susceptibility. The known antiviral agent ara-A was clearly the most toxic of these compounds. Even so, the anaemias which occur clinically are not usually dose limiting with this drug (Bodey et a/., 1975; Sacks et a/., 1982; Quinn et sl., 1987) . Similarly, in recently completed toxicological studies, a prodrug of ara-M exhibited dose limiting neurologic toxicities, although haematologic effects were observed in monkeys (Szczech et et., 1992) .
Thus, the present results should beviewed only as a guide to possible toxicities, rather than as a predictor of their occurrence as limiting toxicities.
The progenitor cells measured in these colony forming assays occur only at low frequency «0.1%) in normal bone marrow cell populations. Thus, large numbers of viable cells must be plated for each assay. The large
Discussion
Table 1. Inhibition of normal human marrow progenitor cell colony formation. Successful therapeutic use of any antiviral agent depends on selective activity of the compound. The degree of selectivity observed in vitro for a given compound may vary as a function of both the cell type and the assay system. The data reported here show that some purine arabinosides can inhibit colony formation by haemopoietic progenitor cells obtained from normal human marrow. Different progenitor cells appear to vary in their susceptibility to inhibition by these compounds. The erythroid precursor BFU-E was much more susceptible to inhibition by these purine arabinosides than was CFU-GM. The number of metabolically active cells in the assay may play a role in transforming compounds to metabolites with either greater or lesser inhibitory potency. In addition, the extended incubations required for colony formation from single cells provides adequate time for such transformations to occur. The potential biotransformation of a compound must be considered in the assessment of its toxicity, both in vitro as well as in vivo.
The potencies of both ara-A and ara-M were significantly altered, but in opposite ways, by including a specific inhibitor of adenosine deaminase in the assays. Ara-A became thirty-fold more potent, whereas ara-M became essentially non-inhibitory. Also, both compounds were substrates for partially purified adenosine deaminase, although their substrate efficiencies were significantly different. These results indicate that these two compounds are converted during the course of the assay to ara-H, and that this transformation is mediated by adenosine deaminase. The ara-H thus generated is a significant inhibitor of erythroid colony formation. In contrast, 6-ethoxypurine arabinoside was not significantly inhibitory in the colony forming assays at the concentrations tested. The fifty-fold difference in substrate efficiency observed for this compound compared to ara-M may account for this.
All these data indicate that the inherent toxicities of these compounds per se are more accurately assessed under conditions where formation of ara-H does not occur. Nevertheless, the value of an in vitro result is enhanced by the occurrence of biotransformation which mimics in vivo metabolism. Conversion of ara-A to ara-H is known to occur in vivo, and this effect was observed in the in vitro progenitor cell assay system described here. Significant conversion of ara-M to ara-H apparently occurred in vitro and was recently shown to occur in vivo (Burnette et al., 1991) . The extent of formation of ara-H may predict the degree to which toxicity occurs after in vivo administration of ara-M, Indeed, it is possible that the formation of ara-H in vivo may be responsible for the neurotoxicity which appears to limit the clinical exploitation of the potent anti-VZV activity of this agent. Arabinoside toxicity to progenitor cells 181 (erythro-9-(2-hydroxy-3-nonyl)adenine) were obtained as previously described (Averett et a/., 1991) .
Colony assays
Normal human bone marrow cells were obtained either from the iliac crest of normal donors or from the ribs of patients undergoing thoracotomy. Mononuclear cells were isolated by Ficoll-Hypaque density centrifugation and further purified by removing the adherent cells by overnight adherence to plastic. Assays for erythroid and granulocyte-macrophage progenitor cells were performed essentially as previously described (Zeldis et el., 1985) , with compounds incorporated into the medium when cells were plated. Briefly, erythroid progenitor cells (CFU-E, BFU-E) were assayed in Iscove's modified Dulbecco's medium (IMDM) in the presence of 0.8% methylcellulose, 30% heat-inactivated fetal bovine serum (FBS), 10% phytohaemaglutinin-stimulated leucocyte conditioned medium (PHA-LCM), 1% deionized bovine serum albumin (Sigma, St Louis, MO, USA), 100 ILM 2-mercaptoethanol, and 2 U ml-1 erythropoietin (Amgen, Thousand Oaks, CA, USA). CFU-E and BFU-E were counted after 7 and 14days of culture, respectively. CFU-GM were assayed in IMDM containing 0.35% agar, 20% FBS, and 5% conditioned medium from cultures of bladder carcinoma 5637 cells (ATCC HTB 9), and 50U mr" recombinant GM-CSF. CFU-GM were scored after 10 days of culture with colonies consisting of greater than 40 cells. All assays were performed in triplicate. Standard deviations were generally less than 20% of mean values. The colony formation data were used to calculate IC 5 0 values according to a log[drug] vs. % inhibition algorithm as previously described (Spector et a/., 1987) .IC 5 0 values obtained in this assay for well-characterized compounds such as AZTwere comparable to those reported using a different but analogous system (Dornsife et et., 1991) .
Adenosine deaminase assays
Calf intestine adenosine deaminase was purchased from Boehringer Mannheim (200 units mg-1 ) and dialyzed against water to remove ammonium sulphate. The ability of compounds to inhibit adenosine deamination was assayed spectrophotometrically at 270nm (extinction change = -5.85mM-1 crrr ") by progress curve analysis (Spector, 1984) . Kinetic constants for the conversion of ara-M or ara-A to ara-H were obtained from initial velocity analysis. The extinction coefficient for the spectral change of both ara-M and 6-ethoxypurine arabinoside was 3.9mM-1 cm' at 269nm. The extinction change for ara-A and adenosine was -8.2mM-1 crrr" at 265nm. All constants were determined at 25°C and pH 6.8. Reaction products were identified by comparison of their UV spectra with that of authentic material.
